Table 2.
Comparison of clinical outcome between Wellens’ and non-Wellens’ group
| Variables, n (%) | Wellens’(N = 200) | No-Wellens’ (N = 1927) | P value |
|---|---|---|---|
| MACCE | 9 (4.5) | 126 (6.5) | 0.26 |
| All-cause death | 4 (2) | 58 (3) | 0.419 |
| Cardiac death | 2 (1) | 34 (1.8) | 0.425 |
| Re-hospitalization | 21 (10.5) | 372 (19.3) | 0.002 |
| Heart failure | 1 (0.5) | 25 (1.3) | 0.329 |
| Target vessel revascularization | 0 | 18 (0.9) | 0.17 |
| Recurrent myocardial infarction | 5 (2.5) | 48 (2.5) | 0.994 |
| Stroke | 2 (1) | 21 (1.1) | 0.907 |
Values are n (%)
MACCE: major adverse cardiac and cerebrovascular events, a composite of all-cause death, cardiac death, recurrent myocardial infarction, target vessel revascularization, heart failure, and stroke